Clinical Trial: A Pharmacokinetic Study of VCT220 With Moderate Renal Impairment Patients
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Obesity & Overweight
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Single-Dose, Open-Label, Parallel-Group Pharmacokinetic Study of VCT220 in Subjects With Moderate Renal Impairment and Matched Subjects With Normal Renal Function
Brief Summary:
This Phase 1 study is designed to evaluate the pharmacokinetics and safety of a single oral dose of VCT220 (other name: CX11) in subjects with moderate renal impairment compared with age-, sex-, and body mass index (BMI)-matched subjects with normal renal function.The results of this study will provide scientific evidence to support appropriate clinical dosing recommendations of VCT220 in subjects with renal impairment.
Read more